Tag: Drug development
Navigating the Debate: Life Sciences Innovation vs. Drug Pricing Advocates
The U.S. Patent and Trademark Office (USPTO) is currently in the midst of a public comment period regarding proposed rule changes on terminal disclaimers, which are used to overcome non-statutory double patenting rejections. As...
FDA Center for Clinical Trial Innovation: Improving Trial Processes and Patient Safety
In April 2024, the U.S. Food and Drug Administration Center for Drug Evaluation and Research (CDER) introduced the Center for Clinical Trial Innovation (C3TI) to enhance communication and collaboration in clinical trials. C3TI aims...